Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H I Nyland

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Medical Hypotheses|January 1, 1995
The role of mast cells and diet in the onset and maintenance of multiple sclerosis: a hypothesisP G Krüger, H I Nyland
Neurology|July 13, 2000
Quality of life as a predictor for change in disability in MSM W Nortvedt, T Riise, K M Myhr, et al.
Neurology|September 25, 1999
Quality of life in multiple sclerosis: measuring the disease effects more broadlyM W Nortvedt, T Riise, K M Myhr, et al.
Medical Care|October 6, 2000
Performance of the SF-36, SF-12, and RAND-36 summary scales in a multiple sclerosis populationM W Nortvedt, T Riise, K M Myhr, et al.
Acta Neurologica Scandinavica. Supplementum|April 28, 2006
FcgammaR and multiple sclerosis: an overviewO Torkildsen, C A Vedeler, H I Nyland, et al.
Acta Neurologica Scandinavica|July 10, 2004
Long-term outcome of cerebral infarction in young adultsH Naess, H I Nyland, L Thomassen, et al.
European Journal of Neurology|February 8, 2005
Mild depression in young adults with cerebral infarction at long-term follow-up: a population-based studyH Naess, H I Nyland, L Thomassen, et al.
European Journal of Neurology|December 25, 2003
Etiology of and risk factors for cerebral infarction in young adults in western Norway: a population-based case-control studyH Naess, H I Nyland, L Thomassen, et al.
Neurology|November 30, 2000
Neutralizing antibodies to interferon (IFN) alpha-2a and IFN beta-1a or IFN beta-1b in MS are not cross-reactiveK M Myhr, C Ross, H I Nyland, et al.
Stroke|August 3, 2002
Incidence and short-term outcome of cerebral infarction in young adults in western NorwayH Naess, H I Nyland, L Thomassen, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Medical Hypotheses|January 1, 1995
The role of mast cells and diet in the onset and maintenance of multiple sclerosis: a hypothesisP G Krüger, H I Nyland
Neurology|July 13, 2000
Quality of life as a predictor for change in disability in MSM W Nortvedt, T Riise, K M Myhr, et al.
Neurology|September 25, 1999
Quality of life in multiple sclerosis: measuring the disease effects more broadlyM W Nortvedt, T Riise, K M Myhr, et al.
Medical Care|October 6, 2000
Performance of the SF-36, SF-12, and RAND-36 summary scales in a multiple sclerosis populationM W Nortvedt, T Riise, K M Myhr, et al.
Acta Neurologica Scandinavica. Supplementum|April 28, 2006
FcgammaR and multiple sclerosis: an overviewO Torkildsen, C A Vedeler, H I Nyland, et al.
Acta Neurologica Scandinavica|July 10, 2004
Long-term outcome of cerebral infarction in young adultsH Naess, H I Nyland, L Thomassen, et al.
European Journal of Neurology|February 8, 2005
Mild depression in young adults with cerebral infarction at long-term follow-up: a population-based studyH Naess, H I Nyland, L Thomassen, et al.
European Journal of Neurology|December 25, 2003
Etiology of and risk factors for cerebral infarction in young adults in western Norway: a population-based case-control studyH Naess, H I Nyland, L Thomassen, et al.
Neurology|November 30, 2000
Neutralizing antibodies to interferon (IFN) alpha-2a and IFN beta-1a or IFN beta-1b in MS are not cross-reactiveK M Myhr, C Ross, H I Nyland, et al.
Stroke|August 3, 2002
Incidence and short-term outcome of cerebral infarction in young adults in western NorwayH Naess, H I Nyland, L Thomassen, et al.
Pageof 3